View email in your browser

SWI QuickPicks Up 21%

Los Angeles, March 18, 2016.  These are still turbulent times, but as of today the Dow is positive for 2016. That is a good start. Add to this that our StockWatchIndex QuickPicks are up 21%, which is another improvement of 7% from the last report. The consistent value increase of our QuickPicks portfolio, even through turbulent times, should be a good reason for you to keep following our coverage. We frequently report the performance of our portfolios for absolute transparency.

Trend Lines
So its easier for you to follow the rise and fall of our individual picks, we update the trend lines for each stock with every report, reflecting its development from the first day of coverage by StockWatchIndex and SWI Research. In this report we have classified 10 stocks with an "Up" trend, 5 with a "Neutral" trend and 3 with a "Down" trend. Come back, so you are not missing out on our updates and new initiations. 

New Initiations
We have initiated coverage on two new stocks, ProQR Therapeutics N.V. (PRQR) and Flamel Technologies SA (FLML), adding to our growing portfolio of biotech/pharmaceutical stocks with good return of investment potential. Keep in mind that many of these companies are still in the development stage and are considered "risky", but can also produce enormous returns, especially when acquired at an early stage. Make sure that you always invest in accordance with your personal risk profile.

ProQR Therapeutics N.V., a bio pharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. The company'Â’s lead product candidate includes QR-010, a RNA-based oligonucleotide that is in Phase Ib clinical trial for the treatment of cystic fibrosis. It also develops QR-110, which is in pre-clinical development stage for the treatment of LeberÂ’'s congenital amaurosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.

Flamel Technologies SA, a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary polymer based technology primarily in the United States and Europe. The company owns and develops drug delivery platforms, such as Micropump that allows generating and marketing modified and/or controlled release of solid and oral dosage formulations of drugs; and LiquiTime, which develops modified/controlled release of liquid formulations for patients having issues swallowing tablets or capsules. Its drug delivery platforms also comprise Trigger Lock that develops abuse-resistant modified/controlled release formulations of narcotic/opioid analgesics and other drugs susceptible to abuse; and Medusa, which develops extended/modified release of injectable dosage formulations of drugs.

Rainer Poertner - Chief Analyst    

Please visit our sites and We would appreciate f you could
pass our newsletter on to your friends and colleagues. We always appreciate your feedback and comments

StockWatchIndex (SWI) is not a registered investment adviser and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in the publications for its Stock Watch List or on its web sites. Some information has been generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in its Stock Watch List or on its web sites. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. StockWatchIndex expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI does not hold any positions in any of the stocks on the QuickPick list and has not been compensated by any of the companies. The included information is subject to change without notice. Please visit for a full text of our Disclaimer, Privacy policy and Terms of Use.
Copyright © 2016 DynamicMarketConcepts, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp